
AMWL Stock Forecast & Price Target
AMWL Analyst Ratings
Bulls say
American Well Corp has demonstrated a robust financial performance characterized by a significant 29.4% year-over-year increase in higher-margin subscription revenue, indicating strong growth potential within its digital health offerings. The company reported an adjusted EBITDA loss of $12.2 million, outperforming both its guidance and consensus estimates, which bodes well for its operational efficiency and financial stability. Additionally, American Well's expectations for a sequential increase in subscription revenue as it rolls out automated programs and digital behavioral health services suggest ongoing momentum and the potential for further revenue enhancement in the upcoming quarters.
Bears say
American Well Corp is facing challenges reflected in their projected operating expenses, particularly in general and administrative (G&A) and sales and marketing (S&M) costs, which are expected to decline significantly by 25.1% and 28.2% year-over-year, respectively, indicating a potential contraction in operational capabilities. Additionally, the company’s guidance appears overly optimistic, as it anticipates a reduction in G&A by only 20%, while projections suggest a deeper cut may be necessary to align with revenue realities. This divergence between internal expectations and external projections signals potential issues in sustainability and financial health moving forward, contributing to a negative outlook for the stock.
This aggregate rating is based on analysts' research of American Well Corporation and is not a guaranteed prediction by Public.com or investment advice.
AMWL Analyst Forecast & Price Prediction
Start investing in AMWL
Order type
Buy in
Order amount
Est. shares
0 shares